Skip to content
Toggle main navigation
TEPHIConnect logo
TEPHIConnect logo
  • Home
  • About
    • About TEPHINET
    • About TEPHIConnect
    • Terms of Use and Privacy
  • How to Join
  • Why Join?
  • News
  • Events
  • Groups
  • Journals
    • BMC Medicine
    • BMC Medical Research Methodology
    • Clinical Epidemiology and Global Health
    • Emerging Microbes & Infections
    • Frontiers in Epidemiology
    • Global Health Journal
    • International Journal of Epidemiology
    • Online Library Journal
    • PLoS One
    • Science Direct Journal (Global Health)
    • Science Direct Journal (Clinical Epidemiology and Global Health)
    Log in
    Request to join

    News

    All
    abstract
    access to care
    acute febrile Illness
    adolescents
    adults
    afenet
    afghanistan
    africa
    african american
    alaskapox
    alumni spotlight
    amazon
    americas
    analysis
    antarctica
    See all

    Results (5)

    New WHO Interim Guidance – IPC for Routine Immunization during the BVD Outbreak

    New WHO Interim Guidance – IPC for Routine Immunization during the BVD Outbreak

    WHO has just released new interim guidance to help keep routine immunization services running safely during the Bundibugyo virus disease (BVD) outbreak:With sincere thanks and appreciation to those who contributed to its development, This interim guidance document provides infection prevention and control considerations to support the safe planning and implementation of routine immunization activi
    August 31, 2026
    Ebola Bundibugyo Virus Disease Outbreak – DRC & Uganda | External Situation Report 11 (Data as of 26 July 2026)

    Ebola Bundibugyo Virus Disease Outbreak – DRC & Uganda | External Situation Report 11 (Data as of 26 July 2026)

    Please find attached the WHO Weekly External Situation Report No. 11 on the Ebola Bundibugyo virus disease outbreak, with data as of 26 July 2026, covering the Democratic Republic of the Congo and Uganda.Click following link or download attachment: EBOLA BUNDIBUGYO VIRUS DISEASE OUTBREAK Democratic Republic of the Congo | Uganda Weekly External Situation Report 11, Data as of 26 July 2026 | WHO |
    August 19, 2026
    Ebola Bundibugyo Virus Disease Outbreak – DRC & Uganda | External Situation Report 09 (Data as of 12 July 2026)

    Ebola Bundibugyo Virus Disease Outbreak – DRC & Uganda | External Situation Report 09 (Data as of 12 July 2026)

    Please find attached the WHO Weekly External Situation Report No. 09 on the Ebola Bundibugyo virus disease outbreak, with data as of 12 July 2026, covering the Democratic Republic of the Congo and Uganda.Click following link or download attachment: EBOLA BUNDIBUGYO VIRUS DISEASE OUTBREAK Democratic Republic of the Congo | Uganda Weekly External Situation Report 09, Data as of 12 July 2026 | WHO |
    July 17, 2026
     Subscribe Save Share Reprints Request 10 years after the 2014–16 Ebola epidemic in west Africa: advances and challenges in African epidemic preparedness

    Subscribe Save Share Reprints Request 10 years after the 2014–16 Ebola epidemic in west Africa: advances and challenges in African epidemic preparedness

    The 2014–16 Ebola virus disease epidemic in west Africa, declared a decade ago on March 23, 2014, left an indelible mark among the 21st-century's various public health emergencies. The epidemic, which primarily affected Guinea, Liberia, and Sierra Leone, took months to identify after a first cluster of cases in December, 2013. It took almost 3 years to contain, and claimed thousands of lives. The
    April 1, 2024
    Oral administration of obeldesivir protects nonhuman primates against Sudan ebolavirus

    Oral administration of obeldesivir protects nonhuman primates against Sudan ebolavirus

    Filoviruses frequently emerge to cause terrifying outbreaks of often-fatal human disease. Treatment options so far have focused on monoclonal antibodies. Remdesivir is an adenosine analog that binds viral RNA polymerase to block replication by premature termination of RNA transcription. The drug has been successfully used intravenously for treating progressive severe acute respiratory syndrome cor
    March 15, 2024
    Contact
    TEPHINET Secretariat

    330 W Ponce de Leon Ave

    Decatur

    GA 30030

    USA

    tephinet@taskforce.org
    +1-404-371-0466
    Links
    • Training Programs in Epidemiology and Public Health Interventions Network (TEPHINET)
    • Privacy Policy
    Cookies
    Reselect cookie settings
    Community engagement platform by Hivebrite.